Superior Cerebrovascular Outcomes with Tirzepatide versus Semaglutide in Diabetic Patients
A study comparing Tirzepatide to Semaglutide in diabetic CABG patients found significant benefits for cerebrovascular and cardiovascular outcomes, reducing mortality and complications.
Target trial emulations for tirzepatide, semaglutide and SGLT2-inhibitors for dementia
A recent study indicates that tirzepatide may reduce incident dementia more than semaglutide or SGLT2 inhibitors in adults with type 2 diabetes.
Cannabis Linked to Lower Weight And Reduced Diabetes Risk in Mouse Study
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchCBDTHCSafetyAgingIndustryHemp Why This Matters Regular cannabis users show lower BMI and reduced diabetes risk in…
Cannabis could treat obesity and diabetes, study finds – leafie
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchAgingHempCBDTHCSafetyIndustry Why This Matters Clinicians should understand that emerging evidence suggests…
New California Study Explores Cannabis for Obesity and Diabetes
This new study highlights cannabis metabolic disorders treatment potential, showing promising effects on obesity and diabetes in preclinical models. Cannabis may influence glucose metabolism and weight regulation, offering new therapeutic avenues.…
What the Latest Physiology Research Reveals About Cannabis Formulation and Diabetes Risk
A Journal of Physiology study from UC Riverside found that whole cannabis extract reversed the fat-to-pancreas signaling failure behind type 2 diabetes—while purified THC alone did not. The findings suggest the entourage effect may have direct…
Cannabis compounds may improve metabolism and reduce diabetes risk
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMetabolic HealthTHCCBDSafety Why This Matters Preclinical evidence that cannabis compounds improve insulin…
CBD Oil for Neuropathy: Is it a Safe Option for Diabetics? | Ubie Doctor’s Note
Diabetic neuropathy affects many patients and remains difficult to treat. CBD oil neuropathy safe option diabetics is a topic of growing clinical interest. Understanding its safety and potential benefits is essential for patients and clinicians.
Can Marijuana Lower Blood Sugar Levels? What the Evidence Actually Shows
Cannabis glucose metabolism research explores how marijuana may affect blood sugar levels and insulin resistance. Current evidence remains inconclusive and inconsistent. Understanding this research is essential for informed clinical guidance.
High-Risk Behavior? What Your Patients Should Know About Cannabis and Diabetes
Cannabis and diabetes management require careful attention to glucose control and patient safety. Understanding how cannabinoids affect insulin sensitivity is essential. Patients should monitor blood sugar closely when using cannabis.